Cargando…

The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs

The broad application of next-generation sequencing technologies in conjunction with improved bioinformatics has helped to illuminate the complexity of the transcriptome, both in terms of quantity and variety. In humans, 70–90% of the genome is transcribed, but only ~2% carries the blueprint for pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Roland, Zander, Sindy, Gutschner, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713356/
https://www.ncbi.nlm.nih.gov/pubmed/29125541
http://dx.doi.org/10.3390/ijms18112387
_version_ 1783283405924859904
author Jacob, Roland
Zander, Sindy
Gutschner, Tony
author_facet Jacob, Roland
Zander, Sindy
Gutschner, Tony
author_sort Jacob, Roland
collection PubMed
description The broad application of next-generation sequencing technologies in conjunction with improved bioinformatics has helped to illuminate the complexity of the transcriptome, both in terms of quantity and variety. In humans, 70–90% of the genome is transcribed, but only ~2% carries the blueprint for proteins. Hence, there is a huge class of non-translated transcripts, called long non-coding RNAs (lncRNAs), which have received much attention in the past decade. Several studies have shown that lncRNAs are involved in a plethora of cellular signaling pathways and actively regulate gene expression via a broad selection of molecular mechanisms. Only recently, sequencing-based, transcriptome-wide studies have characterized different types of post-transcriptional chemical modifications of RNAs. These modifications have been shown to affect the fate of RNA and further expand the variety of the transcriptome. However, our understanding of their biological function, especially in the context of lncRNAs, is still in its infancy. In this review, we will focus on three epitranscriptomic marks, namely pseudouridine (Ψ), N(6)-methyladenosine (m(6)A) and 5-methylcytosine (m(5)C). We will introduce writers, readers, and erasers of these modifications, and we will present methods for their detection. Finally, we will provide insights into the distribution and function of these chemical modifications in selected, cancer-related lncRNAs.
format Online
Article
Text
id pubmed-5713356
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57133562017-12-07 The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs Jacob, Roland Zander, Sindy Gutschner, Tony Int J Mol Sci Review The broad application of next-generation sequencing technologies in conjunction with improved bioinformatics has helped to illuminate the complexity of the transcriptome, both in terms of quantity and variety. In humans, 70–90% of the genome is transcribed, but only ~2% carries the blueprint for proteins. Hence, there is a huge class of non-translated transcripts, called long non-coding RNAs (lncRNAs), which have received much attention in the past decade. Several studies have shown that lncRNAs are involved in a plethora of cellular signaling pathways and actively regulate gene expression via a broad selection of molecular mechanisms. Only recently, sequencing-based, transcriptome-wide studies have characterized different types of post-transcriptional chemical modifications of RNAs. These modifications have been shown to affect the fate of RNA and further expand the variety of the transcriptome. However, our understanding of their biological function, especially in the context of lncRNAs, is still in its infancy. In this review, we will focus on three epitranscriptomic marks, namely pseudouridine (Ψ), N(6)-methyladenosine (m(6)A) and 5-methylcytosine (m(5)C). We will introduce writers, readers, and erasers of these modifications, and we will present methods for their detection. Finally, we will provide insights into the distribution and function of these chemical modifications in selected, cancer-related lncRNAs. MDPI 2017-11-10 /pmc/articles/PMC5713356/ /pubmed/29125541 http://dx.doi.org/10.3390/ijms18112387 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jacob, Roland
Zander, Sindy
Gutschner, Tony
The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs
title The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs
title_full The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs
title_fullStr The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs
title_full_unstemmed The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs
title_short The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs
title_sort dark side of the epitranscriptome: chemical modifications in long non-coding rnas
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713356/
https://www.ncbi.nlm.nih.gov/pubmed/29125541
http://dx.doi.org/10.3390/ijms18112387
work_keys_str_mv AT jacobroland thedarksideoftheepitranscriptomechemicalmodificationsinlongnoncodingrnas
AT zandersindy thedarksideoftheepitranscriptomechemicalmodificationsinlongnoncodingrnas
AT gutschnertony thedarksideoftheepitranscriptomechemicalmodificationsinlongnoncodingrnas
AT jacobroland darksideoftheepitranscriptomechemicalmodificationsinlongnoncodingrnas
AT zandersindy darksideoftheepitranscriptomechemicalmodificationsinlongnoncodingrnas
AT gutschnertony darksideoftheepitranscriptomechemicalmodificationsinlongnoncodingrnas